CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- FinancialsAltman Z-Score 5.16: safe zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
1.24%
Annual Rate
CNY 0.32Paid annual
Payout Ratio
11.8%Sustainable
Payback Period
80.6 yr
Last Ex-Dividend
Jun 5, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
5.68BCNY845.06M · vs all stocks (USD)
Trailing P/E
33.67xRevenue (TTM)
801.40MCNY119.18M · vs all stocks (USD)
Profit Margin
22.11%Beta
0.5490xvs all stocks
52-Week Change
-16.63%vs all stocks
Market Capitalization
5.68BCNY845.06M · vs all stocks (USD)
Enterprise Value
6.21BCNY922.87M · vs all stocks (USD)
Trailing P/E
33.67xForward P/E
22.71xPrice to Sales (TTM)
7.31xPrice to Book (MRQ)
5.21xEnterprise to Revenue
7.74xEnterprise to EBITDA
21.09xGross Margin
59.87%Profit Margin
22.11%Operating Margin
34.74%Return on Assets (TTM)
7.93%Return on Equity (TTM)
16.95%Revenue (TTM)
801.40MCNY119.18M · vs all stocks (USD)
Revenue per Share (TTM)
3.62CNYUpdated Aug 21, 2026Quarterly Revenue Growth
32.50%Gross Profit (TTM)
455.42MCNY67.73M · vs all stocks (USD)
EBITDA (TTM)
279.19MCNY41.52M · vs all stocks (USD)
Net Income (TTM)
177.17MCNY26.35M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
40.80%Operating Cash Flow (TTM)
147.56MCNY21.94M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-100.67MCNY-14.97M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.3200CNYUpdated Aug 21, 2026Trailing Annual Dividend Yield
1.24%vs all stocks
Payout Ratio
11.76%Revenue
741.46MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
313.97MCNYFY2025 · Dec 31, 2025Gross Profit
427.49MCNYFY2025 · Dec 31, 2025Operating Income
235.34MCNY35.00M · vs all stocks (USD)
Pre-tax Income
189.13MCNYFY2025 · Dec 31, 2025Income Tax Expense
31.24MCNYFY2025 · Dec 31, 2025Net Income
157.89MCNYFY2025 · Dec 31, 2025EBIT
204.27MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
279.19MCNYFY2025 · Dec 31, 2025Research & Development
54.91MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
89.96MCNYFY2025 · Dec 31, 2025Other Operating Expenses
7.68MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
1.50MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
15.14MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.7143CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.7143CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
221.09MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
221.09MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
157.89MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
34.44KCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
43.83MCNYFY2025 · Dec 31, 2025Free Cash Flow
-101.84MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
253.09MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
157.89MCNYFY2025 · Dec 31, 2025Other Non-cash Items
19.77MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-79.14MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-54.69MCNYFY2025 · Dec 31, 2025Capital Expenditures
-145.67MCNYFY2025 · Dec 31, 2025Net Acquisitions
1.66MCNYFY2025 · Dec 31, 2025Purchase of Investments
-66.00MCNYFY2025 · Dec 31, 2025Sale of Investments
19.61MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-190.40MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
437.91MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-413.03MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-36.00MCNYFY2025 · Dec 31, 2025Other Financing Charges
71.45MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
60.33MCNYFY2025 · Dec 31, 2025Shares Outstanding
220.34MSharesUpdated Aug 21, 2026Float Shares
134.82MSharesUpdated Aug 21, 2026% Held by Insiders
47.09%vs all stocks
% Held by Institutions
5.23%vs all stocks
Total Cash (MRQ)
297.72MCNY44.27M · vs all stocks (USD)
Total Cash per Share (MRQ)
1.35CNYUpdated Aug 21, 2026Total Debt (MRQ)
576.43MCNY85.72M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.5125xCurrent Ratio (MRQ)
2.12xBook Value per Share (MRQ)
5.10CNYUpdated Aug 21, 2026Total Assets
1.93BCNY287.68M · vs all stocks (USD)
Total Current Assets
881.43MCNYFY2025 · Dec 31, 2025Total Liabilities
876.93MCNYFY2025 · Dec 31, 2025Total Non-current Assets
1.05BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
250.41MCNYFY2025 · Dec 31, 2025Total Current Liabilities
626.52MCNYFY2025 · Dec 31, 2025Cash
278.09MCNYFY2025 · Dec 31, 2025Cash Equivalents
2.96MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
281.05MCNYFY2025 · Dec 31, 2025Other Short-term Investments
20.25MCNYFY2025 · Dec 31, 2025Accounts Receivable
147.24MCNYFY2025 · Dec 31, 2025Inventory
336.17MCNYFY2025 · Dec 31, 2025Accounts Payable
99.57MCNYFY2025 · Dec 31, 2025Short-term Debt
384.97MCNYFY2025 · Dec 31, 2025Other Current Liabilities
61.03KCNYFY2025 · Dec 31, 2025Long-term Debt
150.16MCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
10.98MCNYFY2025 · Dec 31, 2025Common Stock (Book)
157.39MCNYFY2025 · Dec 31, 2025Retained Earnings
534.08MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
1.06BCNY157.28M · vs all stocks (USD)
52-Week Low
20.91CNYUpdated Aug 21, 202652-Week High
33.21CNYUpdated Aug 21, 202652-Week Change
-16.63%vs all stocks
Beta
0.5490xvs all stocks
50-Day MA
25.66CNYUpdated Aug 21, 2026200-Day MA
26.76CNYUpdated Aug 21, 2026Avg 10-Day Volume
11.73MSharesUpdated Aug 21, 2026Avg 30-Day Volume
10.26MSharesUpdated Aug 21, 2026Diluted EPS (TTM)
0.7900CNYUpdated Aug 21, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsWhere is this company structurally exposed?
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 5.16: safe zoneNotable
Altman Z-Score: 5.16
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Genfit S.A.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Anhui Hongyu Wuzhou Medica Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
R&G Pharmastudies Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Pharming Group N.V.
Tier 1ProductionApproval-Gated PipelineRule
Shouyao Holdings Beijing Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Luoxin Pharmaceuticals Group Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Solid Biosciences Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Replimune Group Inc.
Tier 1ProductionApproval-Gated PipelineRule
Gansu Longshenrongfa Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
HK inno.N Corporation
Tier 1ProductionApproval-Gated PipelineRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Anbio Biotechnology Limited
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
Shandong Longda Meishi Co., Ltd.
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
Shanghai Geoharbour Construction Group Co. Ltd.
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated